Price $0.98 |
Market Cap
139.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
1.94
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-58.2K
|
FCF
-
|
|
Op. Margin
-52.10%
|
Net Margin
-64.10%
|
ROE
67.80%
|
ROI
-77.60%
|
|
ROA
-39.40%
|
EPS Growth
55.70%
|
Current Ratio
0.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | $13.41 | - | - | 139.2M | Strong Buy |
| ATI Physical Therapy Inc (ATIP) | $6.00 | - | - | 30.8M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
